Mende, Susanne <br/><br/>
Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model.  [electronic resource] 

 -  Digestive diseases and sciences  May 2013 
 - 1271-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-2568 
<br/><br/><label>Standard No.: </label>10.1007/s10620-012-2499-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B--genetics<br/>Adrenergic beta-Antagonists--pharmacology<br/>Animals<br/>Benzimidazoles--pharmacology<br/>Benzoates--pharmacology<br/>Bile Ducts--drug effects<br/>Cholangitis, Sclerosing--drug therapy<br/>Collagen Type I--metabolism<br/>Collagen Type I, alpha 1 Chain<br/>Cytokines--metabolism<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical<br/>Drug Therapy, Combination<br/>Liver--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Knockout<br/>Myofibroblasts--metabolism<br/>Propranolol--pharmacology<br/>RNA, Messenger--metabolism<br/>Receptor, Angiotensin, Type 1--therapeutic use<br/>Telmisartan<br/>ATP-Binding Cassette Sub-Family B Member 4